← All trials
NCT02641652
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Apr 1, 2016
- Primary completion
- Jun 1, 2018
- Completion date
- Dec 1, 2018
- First posted
- —
- Last posted
- —
- Enrollment
- 136
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- Palacky UniversityLead sponsor
- Palacky UniversityReponsible party - principal investigator
- Palacky UniversityStudy chair
- University of OstravaCollaborator
- Tomas Bata Hospital ZlinCollaborator
- Prerov HospitalCollaborator
- Valasske Mezirici HospitalCollaborator
- Thomayerova Teaching HospitalCollaborator
- Vsetin HospitalCollaborator
- University Hospital BrnoCollaborator
- Medical University of ViennaCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.